CASE STUDY COMPLEX GLOBAL ALLIANCE SUCCESSFULLY EXECUTES CLINICAL TRIALS A pharmaceutical company formed an alliance with a global CRO to plan and execute multiple phase 1/phase II clinical trials for biosimilars to support development in both emerging and regulated markets. The company embraced a “fully outsourced model” and looked to the global CRO to support both the strategic and operational aspects of the clinical development programs.

Join for free to read